Answer
Luveris (lutropin alfa) may increase the risk of an acute attack in people with porphyria or a family history of porphyria, and deterioration or first appearance of the condition may require stopping treatment.
Sources for this answer
- Luveris 75 IUMerck · emc · SmPC §4.4 Special warnings and precautions for use · Version 22Document updated
Sources checked